Highlights Adherium Limited

Equities

ADR

AU000000ADR1

Delayed Australian S.E. Other stock markets 07:20:01 15/05/2024 am IST			5-day change	1st Jan Change
0.018 ^AUD	-5.26%		0.00%	-67.86%

26/04	Adherium Seeks to Raise AU$8.4 Million Via Placement, Entitlement Offer; Shares Fall 24%	MT
15/04	Adherium’s Hailie Smartinhaler Secures FDA Approval for Use with AstraZeneca's Airsupra and Breztri Inhalation Devices	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Adherium Seeks to Raise AU$8.4 Million Via Placement, Entitlement Offer; Shares Fall 24%	26/04	MT
Adherium’s Hailie Smartinhaler Secures FDA Approval for Use with AstraZeneca's Airsupra and Breztri Inhalation Devices	15/04	MT
Adherium Signs Partnership Deal with Rimidi for Asthma Medication	03/04	MT
Adherium's Research Collaboration with US Intermountain, CareCentra Enrolls First Patient	20/03	MT
Adherium Secures AU$1.5 Million R&D Tax Rebate for Fiscal Year 2023	07/03	MT
Adherium Limited Reports Earnings Results for the Half Year Ended December 31, 2023	29/02	CI
Adherium Completes Initial Delivery of Hailie Smart Inhaler Sensors to US Intermountain Health; Shares Jump 6%	18/12	MT
Adherium Completes 1-for-15 Share Consolidation	07/12	MT
Adherium Confirms Enrolment of First Patients at SENTA Partners	21/11	MT
Adherium Launches Next-Generation Respiratory Sensors	09/23/09	MT
Adherium Secures First Patients with US Physician Group	25/23/25	MT
Adherium Enters Partnership for Rollout of Patient Monitoring Platform in US	18/23/18	MT
Adherium Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30/23/30	CI
Adherium Signs Deal to Integrate Respiratory Platform with US Partner	04/23/04	MT
Adherium Gears Up to Commercialize Monitoring Platform in the US	27/23/27	MT
Adherium Secures US FDA Clearance for Use of Sensor on Teva Inhalers	23/23/23	MT
Adherium Limited Receives U.S. FDA 510(k) Clearance for Teva's Proair® and Albuterol Sulphate Inhaler Users to Remotely Monitor Physiological Parameters	23/23/23	CI
Adherium Limited Reports Earnings Results for the Half Year Ended December 31, 2022	27/23/27	CI
Adherium Secures TGA Approval for Respiratory Sensor Device	20/23/20	MT
Adherium Limited Commences Production and Market Release of the New, Next Generation Ellipta Sensor	20/23/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Adherium Limited

Equities

ADR

AU000000ADR1

Highlights

Filters